Levi Strauss & Co
Change company Symbol lookup
Select an option...
LEVI Levi Strauss & Co
CTBI Community Trust Bancorp Inc
$NYLGCAPT NYSE U.S. Large Cap Equal Weight Ind
VIVC Vivic Corp
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC

Consumer Discretionary : Textiles, Apparel & Luxury Goods | Mid Cap Value
Company profile

Levi Strauss & Co. is an apparel company. The Company designs, markets and sells its products under the Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands directly or through third parties and licensees. Its products include jeans, casual and dress pants, tops, shorts, skirts, jackets, footwear, and related accessories for men, women and children across the world. The Company's trademarks include Arcuate Stitching Design, the Tab Device, 501, the Two Horse Design, the Housemark and the Wings and Anchor Design. The Company operates in three geographic segments: the Americas, Europe and Asia. The Company's products are sold in more than 110 countries. The Company licenses its Levi's and Dockers trademarks for a range of product categories in markets in each of its regions, including footwear, belts, wallets and bags, outerwear, sweaters, dress shirts, kidswear, sleepwear and hosiery.


Last Trade
-0.01 (-0.07%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: Wall Street has boosted 2020 estimates for these S&P 500 companies the most

2:24 pm ET February 22, 2020 (MarketWatch)

By Philip van Doorn, MarketWatch

Looking at these stocks may help you spot trends as well as possible bargains or recovery plays

We're getting close to the end of another earnings season, with 77% of S&P 500 companies reporting their results through Feb. 20. Analysts react not only to actual quarterly results, but to changes in companies' guidance (if any) for their fiscal years, as well as industry developments, legal or regulatory challenges as well as world events, such as the coronavirus outbreak.

Higher estimates can push stock prices higher, which may be of particular importance because of how much price-to-earnings valuations have increased for U.S. stocks. The weighted aggregate consensus forward price-to-earnings ratio for the S&P 500 has increased to 19 from 16.3 a year ago. The current forward P/E ratio for the benchmark index is the highest since May 2002, according to data provided by FactSet:

"Reassuringly, topline growth has stayed elevated, at +4%" this earnings season, Mislav Matejka, the head of JPMorgan's global equity strategy, wrote in an earnings-season summary on Feb. 21. He was also noted that "blended EPS growth [actual numbers combined with estimates for companies that hadn't reported yet] for S&P 500 has inflected higher."

Looking at which companies have had their sale and earnings estimates raised the most by analysts since the end of 2019 may help you spot trends as well as possible bargains or recovery plays. If you see anything of interest, always do your own research for more insight into what led to the revised estimates.

Related:Wall Street has slashed these S&P 500 companies' estimates by as much as 70% (http://www.marketwatch.com/story/wall-street-has-slashed-these-sp-500-companies-estimates-by-as-much-as-70-2020-02-21)

The data below includes estimates for calendar 2020.

Largest sales estimate increases

Here are the 20 S&P 500 stocks with the largest increases in consensus 2020 revenue estimates since the end of 2019:

Company Ticker Industry Change in 2020 sales estimate from Dec. 31 to Feb. 20 Increase in 2020 EPS estimate from Dec. 31 to Feb. 20

Centene Corp. US:CNC Managed Health Care 34.5% 0.3%

Prologis Inc. US:PLD Real-estate investment Trusts 27.0% 13.1%

Hasbro Inc. US:HAS Recreational Products 25.3% 9.2%

Vertex Pharmaceuticals Inc. US:VRTX Biotechnology 10.3% 13.6%

Leidos Holdings Inc. US:LDOS Information Technology Services 8.2% 3.5%

Lam Research Corp. US:LRCX Electronic Production Equipment 7.5% 9.2%

T. Rowe Price Group US:TROW Investment Managers 5.4% 9.0%

Applied Materials Inc. US:AMAT Industrial Machinery 5.2% 10.3%

E-Trade Financial Corp. US:ETFC Investment Banks/Brokers 4.7% 3.4%

Garmin Ltd. US:GRMN Telecommunications Equipment 4.3% 7.9%

Regeneron Pharmaceuticals Inc. US:REGN Biotechnology 4.3% 6.1%

Cigna Corp. US:CI Managed Health Care 4.1% -0.2%

BlackRock Inc. US:BLK Investment Managers 3.5% 5.1%

Nvidia Corp. US:NVDA Semiconductors 3.5% 7.1%

Invesco Ltd. US:IVZ Investment Managers 3.3% 1.3%

Apple Inc. US:AAPL Telecommunications Equipment 3.2% 5.1%

Raymond James Financial Inc. US:RJF Investment Banks/Brokers 3.2% 0.2%

Microchip Technology Inc. US:MCHP Semiconductors 3.1% 5.0%

Western Digital Corp. US:WDC Computer Peripherals 3.1% 20.2%

ConocoPhillips US:COP Oil & Gas Production 3.0% -0.6%

Source: FactSet

You can click the tickers for more about each company.

To be sure, sales don't tell the whole story. Cigna (CI) and ConocoPhillips (COP) both had their consensus EPS estimates cut, even as revenue estimates were increased.

Here's a summary of current analyst opinion for the group, including changes in consensus price targets:

Company Ticker share 'buy' ratings Share neutral ratings Share 'sell' ratings Closing price - Feb. 20 Cons. price target Implied 12-month upside potential Change in price target since Dec. 31

Centene Corp. US:CNC 90% 10% 0% $65.73 $81.58 24% 14%

Prologis Inc. US:PLD 83% 11% 6% $98.95 $100.18 1% 6%

Hasbro Inc. US:HAS 59% 41% 0% $98.88 $115.25 17% 0%

Vertex Pharmaceuticals Inc. US:VRTX 76% 24% 0% $245.10 $266.29 9% 13%

Leidos Holdings Inc. US:LDOS 40% 60% 0% $119.27 $119.33 0% 22%

Lam Research Corp. US:LRCX 65% 26% 9% $328.49 $340.05 4% 23%

T. Rowe Price Group US:TROW 35% 53% 12% $137.74 $138.57 1% 12%

Applied Materials Inc. US:AMAT 84% 12% 4% $66.40 $75.22 13% 11%

E-Trade Financial Corp. US:ETFC 50% 50% 0% $54.73 $53.54 -2% 15%

Garmin Ltd. US:GRMN 0% 71% 29% $99.81 $97.25 -3% 15%

Regeneron Pharmaceuticals Inc. US:REGN 37% 63% 0% $399.14 $417.71 5% 6%

Cigna Corp. US:CI 88% 8% 4% $220.41 $252.64 15% 9%

BlackRock Inc. US:BLK 76% 24% 0% $566.92 $591.33 4% 9%

Nvidia Corp. US:NVDA 74% 21% 5% $308.70 $308.95 0% 31%

Invesco Ltd. US:IVZ 17% 66% 17% $18.03 $18.47 2% 2%

Apple Inc. US:AAPL 59% 34% 7% $320.30 $329.58 3% 24%

(MORE TO FOLLOW) Dow Jones Newswires

February 22, 2020 14:24 ET (19:24 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.